Vagus Nerve Stimulation (VNS) Market: By Form (Implantable VNS Devices, External VNS Devices), By Indication (Depression, Epilepsy, Migraine, and Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe) - Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Global Vagus Nerve Stimulation Market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2022 to 2028. Vagus nerve stimulation (VNS) is a sort of neuromodulation. It is intended to change how mind cells function by giving electrical incitement to specific regions associated with seizures. The vagus nerve is a piece of the autonomic sensory system, which controls elements of the body that are not under willful control, (for example, heart rate and relaxing). The vagus nerve sends data from the mind to different regions of the body. It additionally conveys data from the body to the cerebrum.  Global Vagus Nerve Stimulation market is modestly aggressive and broadened because of the nearness of an extensive number of territorial and universal sellers over the globe. These sellers go up against each other in view of components, for example, forceful valuing, item affectability, item separation, innovation update, and administration models. Moreover, a few market players are progressively concentrating on entering associations to grow new items and improve the aggressiveness.

Global Vagus Nerve Stimulation Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Vagus Nerve Stimulation (VNS) Market Dynamics

Ascend in commonness of neurological and cardiovascular issue, increment in geriatric populace, development in help from government and private associations, and presentation of positive repayment arrangements drive the market. In any case, surprising expense of these gadgets and complexities related with vagus nerve stimulation devices market limit the market development. Moreover, high selection rate of negligibly obtrusive VNS methodology and improvement of cutting edge treatments for neurological scatters drive the market development amid the gauge time frame. Nonetheless, mind-boggling expense of gadgets, high support and entanglement identified with vagus nerve stimulation, and stringent administrative endorsements for these gadgets are limiting the development of the global VNS Market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Vagus Nerve Stimulation Market Segmentation

By Type
  • Implantable VNS Devices
  • External VNS Devices
By Indication
  • Depression
  • Epilepsy
  • Migraine
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Medtronic, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Jude Medical, Inc. (U.S.)
  • Synapse Biomedical, Inc. (U.S.)
  • Nevro Corporation (U.S.)
  • Neurosigma, Inc. (U.S.)
  • Neuropace, Inc. (U.S.)
  • Neuronetics, Inc. (U.S.)
  • Cyberonics, Inc. (U.S.)
  • BioControl Medical (Israel)